🕵️ Orchestra Biomed Holdings, Inc. ($OBIO)
SEC insider & ownership activity, last 12 months · CIK 1814114 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. RTW Investments, LP trimmed 19.7% → 19.2%; Roderick Wong trimmed 19.7% → 19.2%. No red-flag 8-Ks in the window.
Insider flow
4 buyers, value withheld pending verification (10 lots) · 2 sellers, $258K (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Sherman Darren | 1 | value withheld pending verification | 4 | $258K | Sep 1, 2026 |
| David P. Hochman | 5 | $149K | 0 | – | Sep 3, 2026 |
| Eric S. Fain | 1 | $83K | 0 | – | May 14, 2026 |
| Aryeh Jason | 3 | $40K | 0 | – | May 18, 2026 |
| RTW Investments, LP | 0 | – | 1 | $132 | Apr 27, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RTW Investments, LP | 19.2% | 13D | Apr 27, 2026 | filing ↗ | |
| Roderick Wong | 19.2% | 13D | Apr 27, 2026 | filing ↗ | |
| Medtronic PLC | 17.8% | 13G | Feb 27, 2026 | filing ↗ | |
| Covidien Group S.A.R.L. | 17.8% | 13G | Feb 27, 2026 | filing ↗ | |
| Perceptive Advisors LLC | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Joseph Edelman | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| RTW Master Fund, Ltd. | 9.6% | 13D | Apr 27, 2026 | filing ↗ | |
| RTW Innovation Master Fund, Ltd. | 8.1% | 13D | Apr 27, 2026 | filing ↗ | |
| Dana Lorenzo | 5.5% | 13G | Nov 19, 2025 | filing ↗ | |
| Tasso Partners, LLC | 5.0% | 13G | Nov 19, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Sherman Darren | $75K | Sep 1, 2026 | filing ↗ |
| Sherman Darren | $61K | Aug 3, 2026 | filing ↗ |
| Sherman Darren | $65K | Jul 1, 2026 | filing ↗ |
| Sherman Darren | $58K | Jun 1, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 24, 2025 | filing ↗ |
| Agreement terminated (1.02) | Oct 24, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 24, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 24, 2025 | filing ↗ |
| Other events (8.01) | Oct 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 24, 2025 | filing ↗ |